Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia
致癌性 NTRK3 突变在急性髓系白血病患者中对原肌球蛋白受体激酶抑制剂表现出不同的敏感性。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.285572
Joshi, Sunil K; Huang, Ariane; Pittsenbarger, Janét; Shinde, Ujwal; Posso, Camilo; Piehowski, Paul D; Gosline, Sara J C; Press, Richard D; Gritsenko, Marina A; Hutchinson, Chelsea; Weitz, Karl K; Watanabe-Smith, Kevin; Long, Nicola; Rodland, Karin D; Tyner, Jeffrey W; Druker, Brian J; Tognon, Cristina E